WBA Insider Trading Activity and SEC Form 4 Filings
WBA insider trading summary
No open-market insider purchases or sales of Walgreens Boots Alliance, Inc. (WBA) have been reported on SEC Form 4 in the past 12 months.
Latest WBA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 27, 2025 | Stefano Pessina | Executive Chairman of Board | Buy | $9.2M (832,258 @ $11.01) |
| Apr 27, 2025 | Stefano Pessina | Executive Chairman of Board | Sell | $9.2M (832,258 @ $11.01) |
| Apr 11, 2024 | Inderpal S Bhandari | Director | Buy | $54K (3,000 @ $18.05) |
| Apr 2, 2024 | Manmohan Mahajan | EVP and Global CFO | Buy | $116K (6,000 @ $19.38) |
| Jan 29, 2024 | Valerie B Jarrett | Director | Buy | $100K (4,456 @ $22.44) |
| Jan 16, 2024 | Nancy M Schlichting | Director | Sell | $351K (15,209 @ $23.05) |
| Jan 5, 2024 | Timothy C Wentworth | Chief Executive Officer | Buy | $242K (10,000 @ $24.22) |
| Nov 10, 2023 | Richard P. Gates | SVP, Chief Pharmacy Officer | Sell | $20K (1,000 @ $20.45) |
| Jun 30, 2023 | John Patrick Driscoll | EVP, Pres. U.S. Healthcare | Buy | $147K (5,172 @ $28.42) |
| Mar 29, 2023 | Rosalind G Brewer | CEO | Buy | $340K (10,000 @ $33.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.